Get the Stockscreener App
22.04
1.05%
-0.235
After Hours:
22.48
0.44
+2.00%
Surgery Partners Inc stock is traded at $22.04, with a volume of 793.05K.
It is down -1.05% in the last 24 hours and down -4.88% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$22.27
Open:
$22.12
24h Volume:
793.05K
Relative Volume:
0.70
Market Cap:
$2.99B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-81.63
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
-0.50%
1M Performance:
-4.88%
6M Performance:
+6.73%
1Y Performance:
-13.74%
1-Day Range:
$21.93
$22.26
1-Week Range:
$21.90
$22.70
52-Week Range:
$18.87
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
22.04 | 2.99B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
376.07 | 87.79B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
27.04 | 16.81B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
175.75 | 14.54B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
118.43 | 12.02B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
182.52 | 11.13B | 16.08B | 1.20B | 1.06B | 17.82 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Surgery Partners: The Plunge Doesn't Justify An Upgrade (NASDAQ:SGRY) - Seeking Alpha
Ascension Buying AmSurg in Response to Outpatient Trend - Healthcare Innovation
U.S. Ambulatory Surgery Center Market Generated - openPR.com
UBS reiterates buy rating on Surgery Partners stock amid takeover rejection - Investing.com
Surgery Partners’ SWOT analysis: stock outlook amid pricing pressures By Investing.com - Investing.com UK
Surgery Partners ends acquisition talks with Bain Capital By Investing.com - Investing.com India
Surgery Partners rejects Bain Capital's takeover proposal - MSN
Surgery Partners Rejects $3.3B Bain Offer - USA Herald
Surgery Partners Ends Buyout Talks with Bain Capital, Shares Slide - GuruFocus
Surgery Partners Rejects $3.3B Bain Offer, Eyes Public Growth - Law360
Surgery Partners rejects Bain Capital's take-private offer - Reuters
Surgery Partners rejects Bain Capital's acquisition offer, opts to remain public - The Business Journals
RSI Alert: Surgery Partners (SGRY) Now Oversold - Nasdaq
Surgery Partners falls after it rejects Bain Capital's take-private offer - TradingView
Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal By Stocktwits - Investing.com India
Bain Capital Private Equity, LP cancelled the acquisition of remaining 60.7% stake in Surgery Partners, Inc.. - MarketScreener
Surgery Partners rejects Bain Capital’s take-private offer - 1470 & 100.3 WMBD
Surgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain Independent - Benzinga
Surgery Partners rejects Bain Capital's takeover proposal (SGRY) - Seeking Alpha
Surgery Partners stock falls after concluding discussions with Bain Capital - Investing.com
Surgery Partners ends acquisition talks with Bain Capital - Investing.com
Surgery Partners Decides to Remain Independent - TipRanks
Surgery Partners (SGRY) Confirms 2025 Financial Projections | SG - GuruFocus
Surgery Partners, Bain Capital conclude discussions - TipRanks
SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions - The Manila Times
Surgery Partners reaffirms FY25 revenue view $3.3B-$3.45B, consensus $3.38B - TipRanks
Surgery Partners (SGRY) Confirms 2025 Financial Projections | SGRY Stock News - GuruFocus
Surgery Partners (SGRY) Decides to Remain Independent Amid Acquisition Proposal | SGRY Stock News - GuruFocus
Surgery Partners stock falls after concluding discussions with Bain Capital By Investing.com - Investing.com South Africa
Surgery Partners Ends Buyout Talks with Bain Capital, Projects $565M EBITDA as Independent Company - Stock Titan
How to Take Advantage of moves in (SGRY) - news.stocktradersdaily.com
Surgery Partners’ SWOT analysis: stock faces pricing pressures amid take-private bid - Investing.com Australia
Surgery Partners’ SWOT analysis: stock faces pricing pressures amid take-private bid By Investing.com - Investing.com South Africa
Tamala Norris-McJunkins: Most Influential Clinical Executives 2025 - Modern Healthcare
California State Teachers Retirement System Has $1.39 Million Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
surgery partners inc. holds annual meeting, approves key proposals - Investing.com Australia
surgery partners inc. holds annual meeting, approves key proposals By Investing.com - Investing.com South Africa
Learn to Evaluate (SGRY) using the Charts - news.stocktradersdaily.com
Surgery Partners Sees 8.2% Sales Growth in Q1 2025 Amid Revenue MissNews and Statistics - IndexBox
SGRY Q1 Earnings Call: Volume Growth and Business Mix Shape Outlook Amid Margin Pressures - Yahoo Finance
Ameriprise Financial Inc. Lowers Position in Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
UBS maintains buy rating for Surgery Partners stock amid AMSURG sale - Investing.com Canada
Surgery Partners gains amid report of AMSURG sale process - MSN
Vicarious Surgical Partners with UMass Memorial to Advance Robotic Surgery - The Healthcare Technology Report.
Surgery Partners Inc (SGRY) Trading 4.94% Higher on May 30 - GuruFocus
Cantor Fitzgerald maintains Overweight on Surgery Partners shares By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains Overweight on Surgery Partners shares - Investing.com
Assessing Surgery Partners: Insights From 4 Financial Analysts - Benzinga
Barclays Maintains Equal Weight Rating on Surgery Partners (SGRY), Cuts PT - MSN
Surgery Partners (SGRY) Target Price Lowered by Barclays | SGRY Stock News - GuruFocus
Surgery Partners price target lowered to $24 from $25 at Barclays - TipRanks
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surgery Partners Inc Stock (SGRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Burkhalter Danielle | Chief Human Resources Officer |
Mar 14 '25 |
Sale |
23.78 |
74 |
1,760 |
44,839 |
| Webb William Trenton | American Group President |
Mar 14 '25 |
Sale |
23.70 |
138 |
3,271 |
74,521 |
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):